Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Study to Determine the Patient Benefit and Safety of Depocyt (Cytarabine Liposome Injection) for the Treatment of Neoplastic Meningitis

NCT00029523 is registered in ClinicalTrials.gov with Pacira Pharmaceuticals, Inc as lead sponsor.

NCT NCT00029523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00029523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Study to Determine the Patient Benefit and Safety of Depocyt (Cytarabine Liposome Injection) for the Treatment of Neoplastic Meningitis
Lead sponsor
Pacira Pharmaceuticals, Inc
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2001
Completion date
November 30, 2004
Enrollment
100
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

meningeal neoplasms